Hope On The Horizon: Tonix Pharmaceuticals (NASDAQ: TNXP) Could Be On the Cusp of Changing Fibromyalgia Treatment Options With TNX-102 SL - Tonix Pharmaceuticals (NASDAQ:TNXP)
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research.
United States Drug Administration University Of North Carolina Tonix Pharmaceuticals Holding Corp Us Department Of Defense Do Registration Enabling Phase
Source: benzinga.com